ArticlePharmacoEconomics - open2025

The Economic and Clinical Impact of Recurring Automated Red Blood Cell Exchange to Manage Sickle Cell Disease in the UK.

Sarah M Medland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.